Real‐world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures

Our favourable clinical experience with emicizumab is similar to that reported in the clinical trials. Notably, this is the largest cohort of patients <12 years without inhibitors treated with emicizumab.